PACE4-Based Molecular Targeting of Prostate Cancer Using an Engineered (64)Cu-Radiolabeled Peptide Inhibitor()()

The potential of PACE4 as a pharmacological target in prostate cancer has been demonstrated as this proprotein convertase is strongly overexpressed in human prostate cancer tissues and its inhibition, using molecular or pharmacological approaches, results in reduced cell proliferation and tumor prog...

Celý popis

Uloženo v:
Podrobná bibliografie
Vydáno v:Neoplasia
Hlavní autoři: Couture, Frédéric, Levesque, Christine, Dumulon-Perreault, Véronique, Ait-Mohand, Samia, D’Anjou, François, Day, Robert, Guérin, Brigitte
Médium: Artigo
Jazyk:Inglês
Vydáno: Neoplasia Press 2014
Témata:
Article
On-line přístup:https://ncbi.nlm.nih.gov/pmc/articles/PMC4235008/
https://ncbi.nlm.nih.gov/pubmed/25220591
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1016/j.neo.2014.07.010
Tagy: Přidat tag
Žádné tagy, Buďte první, kdo otaguje tento záznam!

Podobné jednotky